Patents by Inventor Jae Hwan Ryu

Jae Hwan Ryu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230151078
    Abstract: The present application provides a single-chain blood coagulation factor VIII including a B region which is partially deleted to contain at least four glycosylation sites, but not a region to be cleaved by furin, or a single-chain blood coagulation factor VIII in which the A or B region has some residues pegylated. A single-chain blood coagulation factor VIII according to the present application not only retains intact therapeutic efficacy and can be easily produced on mass scale because of its single chain form, but also has an increased half-life in vivo through pegylation, thus enhancing convenience for patients as a therapeutic agent for hemophilia A and bringing about a reduction of medical expenses through reduction in production cost.
    Type: Application
    Filed: June 23, 2017
    Publication date: May 18, 2023
    Applicant: MOGAM INSTIITUTE FOR BIOMEDICAL RESEARCH
    Inventors: Kwan-Yub KANG, Seung-Hoon LEE, Injae OH, Mee Sook OH, Jae Hwan RYU, Eui-Cheol JO, Ki-Nam LEE, Sun-Ah YANG
  • Patent number: 11046749
    Abstract: A chimera protein according to the present application has a significantly increased in vivo half-life when administered because of a vWF domain coupled to FVIII, such that when used as a hemophilia A therapeutic agent, convenience for patients can be increased and medical expenses can be reduced.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: June 29, 2021
    Assignee: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH
    Inventors: Injae Oh, Seung-Hoon Lee, Eui-Cheol Jo, Mee Sook Oh, Jae Hwan Ryu, Yong Jae Kim, So Ra Kim, Jin-hyun Park
  • Publication number: 20210079062
    Abstract: An in-vivo release-sustained recombinant coagulation factor VIII and a method for making it are disclosed. The recombinant coagulation factor VIII has a biocompatible polymer that is conjugated to at least one sugar chain terminus. The in-vivo release-sustained recombinant coagulation factor VIII has a protein surface modified through a method more elaborate and safer than conventional glycoconjugation techniques and enjoys the advantage of decreasing in immunogenicity and increasing in in-vivo sustainability.
    Type: Application
    Filed: January 11, 2019
    Publication date: March 18, 2021
    Applicant: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH
    Inventors: Kwan Yub KANG, Taeyoon KIM, Jae Hwan RYU, Yeon Jung KIM, Yong Jae KIM
  • Publication number: 20190330311
    Abstract: A chimera protein according to the present application has a significantly increased in vivo half-life when administered because of a vWF domain coupled to FVIII, such that when used as a hemophilia A therapeutic agent, convenience for patients can be increased and medical expenses can be reduced.
    Type: Application
    Filed: June 23, 2017
    Publication date: October 31, 2019
    Applicant: Mogam Institute for Biomedical Research
    Inventors: Injae OH, Seung-Hoon LEE, Eui-Cheol JO, Mee Sook OH, Jae Hwan RYU, Yong Jae KIM, So Ra KIM, Jin-hyun PARK
  • Publication number: 20050072624
    Abstract: The present invention relates to a speaker. The speaker comprises a first cabinet 20 with a predetermined inner space 22 defined therein; a second cabinet 30 in which an inner space 32 communicating with the inner space 22 of the first cabinet 20 is defined so that the inner space 22 is closed from the outside when the second cabinet 30 is engaged with the first cabinet 20; and a sound-generating unit 40 provided in the inner spaces 22 and 32 defined by the first and second cabinets 20 and 30 to generate an acoustic signal. The first and second cabinets 20 and 30 can move relatively with respect to each other, whereby an internal volume of the inner spaces 22 and 32 is changed through adjustment of the length D of the inner spaces 22 and 32 between a front end of the first cabinet 20 and a rear end of the second cabinet 30.
    Type: Application
    Filed: September 8, 2004
    Publication date: April 7, 2005
    Applicant: LG Electronics Inc.
    Inventors: Jae Hwan Ryu, Ki Kim